NJ State Employees Deferred Compensation Plan’s Bristol-Myers Squibb BMY Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-43,884	Closed	-$1.98M	–	56
2025 Q3	$1.98M	Hold	43,884	–	–	0.22%	106
2025 Q2	$2.03M	Hold	43,884	–	–	0.24%	92
2025 Q1	$2.68M	Hold	43,884	–	–	0.34%	69
2024 Q4	$2.48M	Hold	43,884	–	–	0.3%	77
2024 Q3	$2.27M	Hold	43,884	–	–	0.27%	85
2024 Q2	$1.82M	Hold	43,884	–	–	0.23%	95
2024 Q1	$2.38M	Hold	43,884	–	–	0.3%	81
2023 Q4	$2.25M	Hold	43,884	–	–	0.31%	80
2023 Q3	$2.55M	Hold	43,884	–	–	0.39%	59
2023 Q2	$2.81M	Hold	43,884	–	–	0.4%	59
2023 Q1	$3.04M	Hold	43,884	–	–	0.47%	48
2022 Q4	$3.16M	Hold	43,884	–	–	0.51%	50
2022 Q3	$3.12M	Hold	43,884	–	–	0.53%	43
2022 Q2	$3.38M	Hold	43,884	–	–	0.55%	41
2022 Q1	$3.21M	Hold	43,884	–	–	0.43%	58
2021 Q4	$2.74M	Hold	43,884	–	–	0.34%	75
2021 Q3	$2.6M	Hold	43,884	–	–	0.35%	75
2021 Q2	$2.93M	Hold	43,884	–	–	0.39%	64
2021 Q1	$2.77M	Hold	43,884	–	–	0.39%	64
2020 Q4	$2.72M	Hold	43,884	–	–	0.42%	59
2020 Q3	$2.65M	Hold	43,884	–	–	0.48%	50
2020 Q2	$2.58M	Hold	43,884	–	–	0.48%	50
2020 Q1	$2.45M	Hold	43,884	–	–	0.56%	41
2019 Q4	$2.82M	Buy	43,884 +22,000	+101%	+$1.26M	0.48%	46
2019 Q3	$1.11M	Hold	21,884	–	–	0.2%	110
2019 Q2	$992K	Hold	21,884	–	–	0.18%	117
2019 Q1	$1.04M	Sell	21,884 -5,000	-19%	-$249K	0.19%	116
2018 Q4	$1.4M	Hold	26,884	–	–	0.29%	85
2018 Q3	$1.67M	Hold	26,884	–	–	0.28%	83
2018 Q2	$1.49M	Hold	26,884	–	–	0.27%	87
2018 Q1	$1.7M	Hold	26,884	–	–	0.3%	79
2017 Q4	$1.65M	Hold	26,884	–	–	0.29%	82
2017 Q3	$1.71M	Hold	26,884	–	–	0.31%	74
2017 Q2	$1.5M	Hold	26,884	–	–	0.28%	105
2017 Q1	$1.46M	Hold	26,884	–	–	0.28%	112
2016 Q4	$1.57M	Hold	26,884	–	–	0.31%	99
2016 Q3	$1.45M	Hold	26,884	–	–	0.3%	105
2016 Q2	$1.98M	Hold	26,884	–	–	0.42%	62
2016 Q1	$1.79M	Hold	26,884	–	–	0.38%	69
2015 Q4	$1.85M	Hold	26,884	–	–	0.38%	69
2015 Q3	$1.59M	Hold	26,884	–	–	0.34%	83
2015 Q2	$1.79M	Hold	26,884	–	–	0.35%	82
2015 Q1	$1.73M	Hold	26,884	–	–	0.33%	86
2014 Q4	$1.59M	Hold	26,884	–	–	0.31%	91
2014 Q3	$1.38M	Hold	26,884	–	–	0.28%	102
2014 Q2	$1.3M	Hold	26,884	–	–	0.26%	115
2014 Q1	$1.4M	Hold	26,884	–	–	0.29%	98
2013 Q4	$1.43M	Hold	26,884	–	–	0.29%	92
2013 Q3	$1.24M	Hold	26,884	–	–	0.27%	106
2013 Q2	$1.2M	Buy	+26,884	New	+$1.17M	0.28%	99

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's BMY Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 43,884 shares — an estimated $1.98M sold.

NJ State Employees Deferred Compensation Plan first reported a position in BMY in Q2 2013 and held it in 50 quarters. The position peaked at $3.38M in Q2 2022. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

NJ State Employees Deferred Compensation Plan reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 43,884 Bristol-Myers Squibb shares in Q4 2025, an estimated $1.98M.
NJ State Employees Deferred Compensation Plan first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 50 quarters.
NJ State Employees Deferred Compensation Plan's Bristol-Myers Squibb position peaked at $3.38M in Q2 2022.
2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.